Expression of miR‑34a and Ki67 in Nasopharyngeal Carcinoma and the Relationship With Clinicopathological Features and Prognosis

Oncology Letters - Greece
doi 10.3892/ol.2019.11217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Associations Between SOX2 and miR-200b Expression With the Clinicopathological Characteristics and Prognosis of Patients With Glioma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Roles of Β-Catenin, TCF-4, and Survivin in Nasopharyngeal Carcinoma: Correlation With Clinicopathological Features and Prognostic Significance

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Correlation of PDK1 Expression With Clinicopathologic Features and Prognosis of Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Macrofollicular Variant of Papillary Thyroid Carcinoma: Its Clinicopathological Features and Long-Term Prognosis

Endocrine Journal
EndocrinologyMetabolismDiabetes
2009English

The Association of P53 Expression Levels With Clinicopathological Features and Prognosis of Patients With Colon Cancer Following Surgery

Oncology Letters
Cancer ResearchOncology
2017English

Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Clinicopathological Features and Prognosis in Patients With Idiopathic Membranous Nephropathy With Hypertension

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

The Association of HMGB1 Expression With Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review

PLoS ONE
Multidisciplinary
2014English

Relationship Between Survivin Expression and Recurrence, and Prognosis in Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy